Atlas

FDA-Inspected Site

OHM Pharma, Inc.

11 FDA inspections are on record for OHM Pharma, Inc. in Mineral Wells, United States.

483· Form 483 issued

Mineral Wells, United States · Last updated July 10, 2026

Overview

  • 11 FDA inspections are on record.
  • 6 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-04-29.

At a glance

Inspections

11

Form 483s

6

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
21 Apr 2025 – 29 Apr 2025Human Drugs483View 483 →
18 Mar 2024 – 28 Mar 2024Foods & Cosmetics483View 483 →
13 Jul 2022 – 29 Jul 2022Foods & Cosmetics483View 483 →
13 Jul 2022 – 14 Jul 2022Foods & CosmeticsClean
28 Oct 2021 – 19 Nov 2021Human DrugsClean
24 Feb 2020 – 18 Mar 2020Human Drugs483On file
14 May 2019 – 23 May 2019Human DrugsWLOn file
13 Oct 2015 – 20 Oct 2015Human DrugsClean
30 Nov 2012Not recorded483View 483 →
17 Jul 2007Not recordedClean
29 Sep 2003Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

29 Apr 2025
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Camerson E Moore, Nadeem I Chaudhry

29 Apr 2025
21 CFR 211.63

Equipment Design, Size and Location

Cited by Camerson E Moore, Nadeem I Chaudhry

28 Mar 2024
21 CFR 111.70(e)

Specifications - identity, purity, strength, composition

Cited by Vitaliy N Guyvan

28 Mar 2024
21 CFR 111.75(h)(2)

Tests, examinations - scientifically valid

Cited by Vitaliy N Guyvan

28 Mar 2024
21 CFR 111.75(h)

Tests, examinations - scientifically valid

Cited by Vitaliy N Guyvan

Investigators

FDA investigators tied to this site in the record.

Camerson E Moore2 insp.
Denise Connelly2 insp.
Nadeem I Chaudhry1 insp.
Vitaliy N Guyvan1 insp.
Lisa R Whitt1 insp.
Charles D Brown1 insp.
Khunnathee Stoner1 insp.
Noreen Muniz1 insp.
Patty P Kaewussdangkul1 insp.
Anh Lac1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 111.70(e)Cited across public-safe Form 483 observations2x
21 CFR 111.75(h)(2)Cited across public-safe Form 483 observations2x
21 CFR 111.113(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.15(i)Cited across public-safe Form 483 observations1x
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.75(h)Cited across public-safe Form 483 observations1x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.166(c)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(1)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind OHM Pharma, Inc.'s 6 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat